Augmented Susceptibility of CDDP-Treated Human Pancreatic Cancer Cell Line, PH101, to Lysis by Effector Lymphocytes.
Yoshiyuki Yamaguchi(Hiroshima University), Tetsuya Toge(Hiroshima University), Mahito Funakoshi(Hiroshima University), Kousuke Noma, I Takashima(Hiroshima University), Eiji Miyahara(Hiroshima University)
Cited by 0
Related Papers
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111